Which Country to Go After Failed IVF in China: Overseas Assisted Reproduction Destination Selection and Decision Guide

Opening: Real Consultation Scenario

A 40-year-old woman with AMH 0.6 ng/mL experienced two failed IVF attempts in China. The first retrieval yielded 3 eggs, none of which formed a transferable embryo; the second retrieval yielded 2 eggs, forming one Day 3 embryo which did not implant after transfer. Her question is straightforward: I've tried domestically with poor results. Could changing to a different environment and technology abroad offer a chance? If so, which country is more suitable?

This is not an isolated case. In reproductive clinics and consultations, similar questions arise almost daily. Deciding whether to pursue overseas treatment after failed IVF in China, and how to choose a destination, requires a comprehensive assessment combining the reasons for failure, age, ovarian function, budget, time, and understanding of different healthcare systems. The following breaks down this issue from multiple dimensions.

1. After Failed IVF in China, What Are the Main Overseas Options?

Currently, the primary overseas destinations for Chinese patients seeking IVF are concentrated in the following countries/regions: United States, Japan, Thailand, Russia, Malaysia, in addition to smaller options like Cambodia, Mexico, and Greece. Each country has distinct differences in technical focus, legal policies, cost ranges, and process efficiency.

The basic logic of choice is not "which country has the highest success rate," but "which country's technical characteristics and legal environment match your specific problem." For example, someone with low ovarian reserve and someone with a poor uterine environment will have completely different suitable directions.

2. Why Does IVF Fail in China? Analysis of Common Reasons

Before discussing which country to go to, it is essential to clarify the reason for failure. According to clinical reproductive medicine statistics, the main reasons for IVF failure in China are concentrated in the following areas:

• Age and Diminished Ovarian Reserve: For women over 40 with AMH below 1.0, low antral follicle count, insufficient egg retrieval, and poor embryo quality are the main bottlenecks.
• Embryo Chromosomal Abnormalities: The rate of embryonic aneuploidy increases significantly with age. For women over 40, even if blastocysts form, the normal chromosome rate may be less than 30%.
• Uterine Environment Issues: Inadequate endometrial thickness, chronic endometritis, intrauterine adhesions, adenomyosis, etc., affect implantation.
• Ovarian Stimulation Protocols and Laboratory Conditions: Inappropriate protocols for the individual, or insufficient laboratory culture systems and embryo assessment experience, leading to poor embryo developmental potential.
• Immune and Coagulation Factors: Some cases of recurrent implantation failure are related to immune disorders or pre-thrombotic states.

Different causes correspond to different overseas directions. For example, those with poor ovarian function are better suited to centers experienced in mild stimulation or natural cycle protocols; those with embryo chromosomal issues require institutions with mature PGT technology and legal permission.

3. Technical Characteristics and Suitable Populations of Different Countries

The following compares major destinations across dimensions such as technology, law, cost, time, and language barriers.

Main Limitations of Each Country

• United States: High cost, lengthy visa process, significant jet lag, some centers have waiting lists.
• Japan: Significant language barrier, limited medical translation resources, egg donation nearly impossible.
• Thailand: Frequent legal policy changes, need to confirm current compliance.
• Russia: Geopolitical instability, long flight times, high language communication costs.
• Malaysia: Relatively limited technical ceiling, may lack experience with complex cases.

4. Doctor's Perspective: How to Choose a Country Based on Failure Reason

From a reproductive doctor's viewpoint, moving overseas after failed IVF in China is fundamentally about solving "the link that couldn't be resolved domestically."

• If due to low ovarian reserve and difficulty retrieving eggs: Japan's mild stimulation protocol has unique advantages; some centers have extensive experience with Day 3 embryos. The US also offers individualized mild stimulation but at a higher cost.
• If due to recurrent failure from embryo chromosomal abnormalities: The US has the most mature PGT technology and legally allows comprehensive chromosome screening of blastocysts. Thailand and Russia also offer PGT, but laboratory qualifications need verification.
• If due to uterine environment issues: It is recommended to complete hysteroscopic examination and treatment in China first, confirming endometrial status is adequate before considering transfer, rather than simply changing countries.
• If egg donation is needed: The US, Russia, and Cambodia have clear legal allowances and relatively abundant egg bank resources; Japan and Malaysia have many restrictions on egg donation.

5. Details Most Easily Overlooked

In the decision-making process, several details are often overlooked but can significantly impact the final outcome.

• Laboratory Quality Assessment: More important than success rate numbers is the laboratory's quality control system. Check for experience in blastocyst culture, PGT laboratory certification, and the embryologist's years of experience.
• Timeliness of Legal Policies: Laws in countries like Thailand and Cambodia have changed in recent years. The compliance of egg donation, surrogacy, and embryo genetic testing needs real-time confirmation; do not rely on old information.
• Professionalism of Medical Translation: The quality of medical translation varies greatly in non-English speaking countries. An inaccurate translation can lead to misunderstandings in treatment plans. Confirm if the translator has a medical background.
• Passport and Visa Validity: Overseas IVF typically requires a stay of at least 15-30 days, and some countries require multiple entries. A passport validity of less than 6 months may affect visa applications and entry.
• Mutual Recognition of Test Reports: Whether overseas institutions accept domestic tests like hormone panel, AMH, semen analysis, and chromosome karyotyping, or if they need to be redone, directly impacts time costs.

6. Common Pitfalls to Avoid

Based on industry observations, the following situations are most common and problematic for Chinese patients choosing overseas IVF.

• Misled by "Success Rate Over 80%": Many overseas institutions advertise success rates based on specific populations (e.g., under 30, egg donation recipients), which do not represent your personal success rate. Ask for statistics specific to your age group.
• Neglecting Physical Preparation Before Going Abroad: Overseas centers may suggest "come first for evaluation," but if you have issues like endometrial polyps, intrauterine adhesions, or thyroid dysfunction, it's best to address them in China first; otherwise, treatment may be paused upon arrival.
• Underestimating Total Costs: Besides medical fees, factor in accommodation, meals, translation, transportation, and multiple round-trip flights. A single stimulation + transfer cycle in the US can exceed 250,000 CNY, and Japan is around 150,000 CNY. If the first cycle fails, second-cycle costs need advance planning.
• Choosing an Agency Instead of Direct Hospital Contact: Some agencies recommend centers they have partnerships with, rather than those truly suitable for you. It is advisable to communicate directly with the hospital's international department or patient coordinator, or obtain information through an independent third party.
• Ignoring Psychological and Time Costs: Overseas IVF requires leaving a familiar environment and waiting for results in a foreign country, which can be more stressful for couples than domestic treatment. Timewise, from initial consultation to transfer usually takes 2-6 months, requiring work arrangements.

7. Basic Process of Overseas IVF

Regardless of the country chosen, the general process for overseas IVF is roughly as follows, though the specific sequence and timing vary by country and individual plan.

1. Pre-examination in China: Complete AMH, hormone panel, semen analysis, chromosome karyotyping, infectious disease screening, and hysteroscopy (if needed). These reports can be used for remote consultation.
2. Remote Video Consultation: Communicate with the overseas doctor online, submit reports, and receive a preliminary plan and medication recommendations.
3. Passport, Visa, and Travel Preparation: Ensure passport validity exceeds 6 months, apply for a medical or tourist visa, and book flights and accommodation.
4. Fly to Destination Country During Menstruation: It is generally recommended to arrive on day 2-3 of menstruation to begin monitoring for the stimulation cycle.
5. Ovarian Stimulation and Egg Retrieval: Depending on the protocol, stimulation lasts about 10-14 days. Egg retrieval is usually performed under anesthesia, with 1-2 days of post-operative observation.
6. Embryo Culture and PGT (if needed): Blastocysts form 5-7 days after retrieval. If PGT is required, biopsy is performed and sent for testing, with a waiting time of about 2-4 weeks.
7. Frozen or Fresh Embryo Transfer: Determined by endometrial preparation and protocol. Pregnancy test is done 12-14 days after transfer.
8. Return Home or Continue Luteal Support: After confirming pregnancy, bring medication back to China for subsequent luteal support and prenatal care coordination.

The entire process from the first visit to transfer completion takes at least 4-6 weeks. If PGT or multiple cycles are involved, the time may extend to 3-6 months.

8. Frequently Asked Questions

Question 1: After multiple failed IVF attempts in China, how long is the wait for egg donation abroad?

In the US and Russia, the wait time for egg donation is relatively short, typically 1-6 months, depending on specific requirements like blood type, ethnicity, height, and education. Egg donation is nearly impossible in Japan, and in Thailand, current legal permission needs confirmation.

Question 2: My AMH is only 0.4. Is it worth going abroad?

It is possible, but goals must be clear. AMH 0.4 indicates severely diminished ovarian reserve, and the number of eggs obtainable is very limited. Japan's mild stimulation protocol may yield 1-2 eggs per cycle, making an embryo accumulation strategy feasible; the US can also do it, but the cost-output ratio needs evaluation. If finances allow, egg donation is a more direct path.

Question 3: Is pre-treatment preparation needed before overseas IVF? How long does it take?

Yes, it is needed. Regardless of the destination, egg and sperm quality are affected by physical condition. It is generally recommended to start supplementing with Coenzyme Q10, Vitamin D, folic acid, etc., 3 months in advance, adjust sleep and weight, and control blood sugar and thyroid function. Men should stop smoking and drinking 3 months in advance and supplement with zinc and selenium.

Question 4: Does the male partner have to go every time for overseas IVF?

Not necessarily. The male partner must be present on the day of egg retrieval to provide a semen sample. If unable to travel, some countries allow frozen semen transport, but legal and logistics conditions need to be confirmed in advance. Initial consultation and file creation usually require both parties to be present or via video witnessing.